ABOVITA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,943,738 | 1,528,548 | 1,294,257 | 1,266,315 | 1,295,968 | 1,326,198 | 1,539,109 | 1,645,949 |
| Profit before tax | 230,391 | 202,234 | 112,227 | 68,917 | 18,775 | 71,702 | 161,722 | 188,029 |
| Net profit | 195,874 | 171,952 | 95,383 | 58,918 | 16,331 | 62,034 | 138,262 | 159,260 |
| Equity | 199,060 | 175,138 | 98,569 | 62,104 | 14,517 | 65,220 | 141,448 | 197,446 |
| Liabilities | 430,019 | 100,527 | 233,252 | 197,041 | 257,211 | 398,110 | 370,050 | 412,991 |
| Non-current assets | 92,091 | 60,520 | 83,439 | 122,872 | 192,874 | 273,294 | 291,632 | 338,438 |
| Current assets | 530,913 | 211,023 | 247,490 | 136,192 | 78,740 | 187,777 | 217,336 | 269,521 |
| Total assets | 623,004 | 271,543 | 330,929 | 259,064 | 271,614 | 461,071 | 508,968 | 607,959 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 249,468 | 331,381 | 380,014 |
| Social insurance contributions | - | - | - | - | - | 3,374 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -4.8% | -21.4% | -15.3% | -2.2% | +2.3% | +2.3% | +16.1% | +6.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 31.4% | 63.3% | 28.8% | 22.7% | 6.0% | 13.5% | 27.2% | 26.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.4% | 98.2% | 96.8% | 94.9% | 112.5% | 95.1% | 97.7% | 80.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 10.1% | 11.2% | 7.4% | 4.7% | 1.3% | 4.7% | 9.0% | 9.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.9% | 13.2% | 8.7% | 5.4% | 1.4% | 5.4% | 10.5% | 11.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.2 | 0.6 | 2.4 | 3.2 | 17.7 | 6.1 | 2.6 | 2.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 158,672 | 156,774 | 150,788 | 183,081 | 263,585 | 442,066 | 513,036 | 548,650 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ABOVITA - Social security debts
The company had no debts to Sodra
ABOVITA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-05 | 2025-04-25 | 0.7 |
| 2025-04-04 | 2025-04-04 | 9463.36 |
| 2025-03-28 | 2025-04-03 | 0.7 |
| 2025-03-20 | 2025-03-24 | 0.7 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ABOVITA, UAB (code 125380554) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €1.65M, up 6.9% year on year and 24.1% over two years, showing a steady upward trend. Net profit reached €159.3K, compared with €138.3K in 2024 and €62.0K in 2023, while profit margin improved from 4.7% to 9.0% and then to 9.7% in 2025. The business remained profitable throughout the period, with pre-tax profit increasing to €188.0K in 2025. The balance sheet also expanded: total assets rose to €608.0K, equity to €197.4K, and liabilities to €413.0K. Long-term assets were €338.4K and short-term assets €269.5K at year-end 2025. Key efficiency indicators were strong, with return on equity at 80.7%, return on assets at 26.2%, asset turnover at 2.71x, and revenue per employee at €548.6K. Overall, the company showed consistent growth in revenue, profitability, and asset base in 2025.